Germany, June 1 -- Germany based Heumann Pharma GmbH & Co. Generika KG has secured contract from DAK-Gesundheit for Pharmaceutical products conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient colchicine ATC M04AC01 for the period 01082025 - 31072027 plus extension option 1x12 months . The value of the contract is not disclosed .
Published by HT Digital Content Services with permission from Pivotal Sources....